Researchers develop artery-on-a-chip platform to predict stroke risk

Much more important would be stopping this risk from occurring. WHOM will you be contacting to get that research done?

Researchers develop artery-on-a-chip platform to predict stroke risk

Predicting an individual's risk of ischemic stroke is difficult because thrombosis embolization-the process of a blood clot detaching from the area where it formed and traveling to and then sticking in another blood vessel-is based on factors that are unique to each person. In a study publishing in the Cell Press journal Cell Biomaterials on July 23, researchers developed a tool to get around this challenge: an artery-on-a-chip platform that can replicate a patient's specific vascular structure and blood flow dynamics, called a "physical twin." 

This idea was born out of a critical clinical gap. We know that even patients at 'low risk' can suffer from severe or fatal strokes. We wanted to find a better way to predict this risk." 

Lining Arnold Ju, Author, University of Sydney, Australia

Ischemic strokes occur when a blood vessel supplying the brain is blocked, usually by a clot or fatty plaque. When vital blood and oxygen are cut off, brain cells die within minutes. For this reason, it's important to find new ways to predict who is at highest risk so that better interventions can be developed. 

"Our work recreates precise, patient-specific carotid artery geometries," says Ju." The physical twin also uses cells that more closely mimic the dynamics of blood flow in these structures. 

The researchers reconstructed carotid arteries from six patients with varying degrees of disease. They used computational fluid dynamics to calculate how blood flowed through each artery, revealing substantial differences in local blood flow despite similar levels of narrowing. After using a laser to create a small injury in the underlying collagen, they also observed strikingly different clotting behaviors depending on the artery's shape. 

Event guide: 10th CAR-TCR Summit eBook Navigate the latest developments in cell therapy at the 10th CAR-TCR Summit Europe.Download the latest edition

"Our findings suggested that three-dimensional vascular shape and local flow disturbances matter far more than simple narrowing," says first author Yunduo Charles Zhao of the Heart Research Institute in Newtown, Australia, who was motivated to shift his research toward predictive stroke diagnosis during his PhD, when his grandmother passed away from stroke. 

"We hope these tools will allow us to study drugs aimed at reducing the risk of stroke and to eventually provide personalized treatments for each patient based on their anatomy." 

The team is currently recruiting stroke patients for a clinical trial to evaluate how this technology can directly benefit underserved stroke patients. They say this technology also has the potential to study other cardiovascular conditions, including peripheral artery disease, deep-vein thrombosis, and aneurisms. 

This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, NSW Cardiovascular Capacity Building Program, MRFF Cardiovascular Health Mission Grants, MRFF Early to Mid Career Researchers Grant, Ramaciotti Foundations; National Heart Foundation, Office of Global and Research Engagement, and University of Sydney Drug Discovery Initiative. 

Source:

Cell Press

Journal reference:

Zhao, Y. C., et al. (2026). Patient-specific carotid artery-on-a-chip 'physical twin' dissects complex flow-dependent VWF mechanopresentation. Cell Biomaterials. DOI: 10.1016/j.celbio.2026.100541. https://www.cell.com/cell-biomaterials/fulltext/S3050-5623(26)00197-2